Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?

BACKGROUND: This study was designed to investigate whether pretreatment of bone marrow mesenchymal stem cells (BMSCs) with 5-azacytidine (5-aza) or double intravenous infusion could enhance their therapeutic potential for dilated cardiomyopathy (DCM). MATERIAL/METHODS: BMSCs were cultured for 2 week...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Sirui, Piao, Jinhua, Jin, Lianhua, Zhou, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2013
Materias:
In Vitro / In Vivo Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638670/
https://www.ncbi.nlm.nih.gov/pubmed/23314418
http://dx.doi.org/10.12659/MSMBR.883737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638670/
https://www.ncbi.nlm.nih.gov/pubmed/23314418
http://dx.doi.org/10.12659/MSMBR.883737

Ejemplares similares